OPKO Health (OPK) And Entera Bio Announce Data for GLP-2
https://www.zacks.com/stock/news/2245547/opko-health-opk-and-entera-bio-announce-data-for-glp-2?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2245547
Mar 25, 2024 - OPKO Health (OPK) and Entera Bio announce robust pharmacokinetic results for the proprietary GLP-2 agonist developed by OPK Heath.
0
bluebird bio Is Priced Below IP Value
https://seekingalpha.com/article/4680031-bluebird-bio-is-priced-below-ip-value?source=feed_all_articles
Mar 22, 2024 - bluebird bio's stock plummeted by 64% on safety concerns and high pricing for sickle cell treatment. Read why its potential sale value remains higher than its market cap.
0
Adicet Bio (ACET) Loses -16.39% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
https://www.zacks.com/stock/news/2244747/adicet-bio-acet-loses-16-39-in-4-weeks-here-s-why-a-trend-reversal-may-be-around-the-corner?cid=CS-ZC-FT-tale_of_the_tape|rsi-2244747
Mar 22, 2024 - The heavy selling pressure might have exhausted for Adicet Bio (ACET) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
0
TELA Bio, Inc. (TELA) Q4 2023 Earnings Call Transcript
https://seekingalpha.com/article/4679785-tela-bio-inc-tela-q4-2023-earnings-call-transcript?source=feed_sector_transcripts
Mar 21, 2024 - TELA Bio, Inc. (NASDAQ:NASDAQ:TELA) Q4 2023 Earnings Conference Call March 21, 2024 4:30 PM ETCompany ParticipantsLouisa Smith - Vice President, Gilmartin...
0
TELA Bio, Inc. (TELA) Reports Q4 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2244443/tela-bio-inc-tela-reports-q4-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2244443
Mar 21, 2024 - TELA Bio (TELA) delivered earnings and revenue surprises of -20.45% and 2.09%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Bayer-backed Boundless Bio sets terms for $100M IPO
https://seekingalpha.com/news/4082227-bayer-back-boundless-bio-sets-terms-for-100m-ipo?source=feed_sector_healthcare
Mar 21, 2024 - Bayer-backed Boundless Bio (BOLD), an oncology drug developer, has set terms for a proposed $100M initial public offering. Read more here.
0
Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 211.71%: Read This Before Placing a Bet
https://www.zacks.com/stock/news/2244067/wall-street-analysts-think-annovis-bio-anvs-could-surge-211-71-read-this-before-placing-a-bet?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2244067
Mar 21, 2024 - The mean of analysts' price targets for Annovis Bio (ANVS) points to a 211.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
0
2seventy bio appoints Eli Casdin and Charles Newton to its board of directors
https://seekingalpha.com/news/4081841-2seventy-bio-appoints-eli-casdin-and-charles-newton-to-its-board-of-directors?source=feed_sector_healthcare
Mar 20, 2024 - 2seventy bio (TSVT) announces the appointment of Eli Casdin and Charles Newton to its board of directors.
0
Why Bluebird Bio Stock Flew Higher Than the Market Today
https://www.fool.com/investing/2024/03/18/why-bluebird-bio-stock-flew-higher-than-the-market/?source=iedfolrf0000001
Mar 18, 2024 - The company was thrown a financial lifeline.
0
Are Medical Stocks Lagging Adicet Bio (ACET) This Year?
https://www.zacks.com/stock/news/2241353/are-medical-stocks-lagging-adicet-bio-acet-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2241353
Mar 15, 2024 - Here is how Adicet Bio, Inc. (ACET) and Adma Biologics (ADMA) have performed compared to their sector so far this year.
0